- $228.44m
- $178.20m
- $616.56m
- 93
- 97
- 24
- 83
Annual income statement for DocGo, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 94.1 | 319 | 441 | 624 | 617 |
Cost of Revenue | |||||
Gross Profit | 31.3 | 110 | 155 | 195 | 214 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 109 | 303 | 420 | 609 | 596 |
Operating Profit | -14.8 | 15.5 | 20.5 | 15.1 | 20.4 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -14.6 | 19.8 | 22.8 | 16.3 | 27.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -14.8 | 19.2 | 30.7 | 10 | 13.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -14.4 | 23.7 | 34.6 | 6.86 | 20 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -14.4 | 23.7 | 34.6 | 6.86 | 20 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.246 | 0.249 | 0.354 | 0.071 | 0.219 |